GR3005654T3 - - Google Patents

Info

Publication number
GR3005654T3
GR3005654T3 GR920401967T GR920401967T GR3005654T3 GR 3005654 T3 GR3005654 T3 GR 3005654T3 GR 920401967 T GR920401967 T GR 920401967T GR 920401967 T GR920401967 T GR 920401967T GR 3005654 T3 GR3005654 T3 GR 3005654T3
Authority
GR
Greece
Prior art keywords
quinazolinone
tetrazol
pharmaceutically acceptable
acceptable salts
uric acid
Prior art date
Application number
GR920401967T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005654T3 publication Critical patent/GR3005654T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR920401967T 1986-10-14 1992-09-10 GR3005654T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/918,405 US4757075A (en) 1986-10-14 1986-10-14 Tetrazolylquinazolinones as anti-hyperuricemic agents

Publications (1)

Publication Number Publication Date
GR3005654T3 true GR3005654T3 (el) 1993-06-07

Family

ID=25440323

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401967T GR3005654T3 (el) 1986-10-14 1992-09-10

Country Status (7)

Country Link
US (1) US4757075A (el)
EP (1) EP0267442B1 (el)
JP (1) JPS63104975A (el)
AT (1) ATE80300T1 (el)
DE (1) DE3781638T2 (el)
ES (1) ES2044888T3 (el)
GR (1) GR3005654T3 (el)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543928B2 (en) * 1981-01-16 1985-05-09 Masayuki Ishikawa 4(311)-quinazolinone derivatives
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
US4599336A (en) * 1983-08-08 1986-07-08 Hoffmann-La Roche Inc. Derivatives of (E)-3-(4-oxo-4H-quinazolin-3-yl)-2-propenamide

Also Published As

Publication number Publication date
EP0267442A3 (en) 1990-05-09
EP0267442A2 (en) 1988-05-18
DE3781638D1 (de) 1992-10-15
ES2044888T3 (es) 1994-01-16
EP0267442B1 (en) 1992-09-09
DE3781638T2 (de) 1993-01-28
ATE80300T1 (de) 1992-09-15
JPS63104975A (ja) 1988-05-10
US4757075A (en) 1988-07-12

Similar Documents

Publication Publication Date Title
IE882583L (en) Treatment of wounds
EP0347252A3 (en) Method of treating cachexia and certain new compounds for use in this method
AU4059485A (en) Substituted benzopyrans
NO931980L (no) Angiotensin II-antagoniserende imidazolderivater, deres fremstilling og terapeutiske anvendelse
GR3005654T3 (el)
OA09027A (fr) Procédé d'inhibition. d'un virus
IL88513A0 (en) D1-5-((2-benzyl-3',4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidine-2',4-dione as an anti-atherosclerosis agent
EP0313945A3 (de) Mittel zur Behandlung des Bluthochdrucks und der Herzinsuffizienz
PT85866A (en) Process for the preparation of therapeutic agents for the treatment of peptic ulcers containing 1,2,3,6-tetrahydro-3-methyl-1-(5-oxohexyl)-7-propyl-purine,6-dione and their derivatives
AU570604B2 (en) Process for the preparation of tetrazolyl 4(3h) quinazolinones
AU7119987A (en) Method of lowering uric acid blood levels in humans
EP0296695A3 (en) Hypouricaemic agent containing ponalrestat
ES2001646A6 (es) Un procedimiento para preparar derivados de espiro(benzofuran-2(3h),1'-cicloheptano.
BG41552A1 (en) Method for preparing of 7- chloro- 1- methyl- 5- phenyl- 1h- 1, 5- benzodiazepin- 2, 4- (3h, 5h)- dion
SE8605216D0 (sv) Novel medicinal use